| Factor Information | |
|---|---|
| Data ID | 710 |
| Factor | WHO function class |
| Description | class I, II(%) |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | APAH-CHD |
| p Value | 0.011 |
| Conclusion | Patients in the lower Cp group experienced advanced WHO function class. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 477 |
| CHD Type | isolated CHD |
| CHD Subtype | CHD with PAH/EA |
| Reference | |
|---|---|
| PMID | 28966315 |
| Year | 2017 |
| Title | Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | data | |
| Region | China, Beijing | |
| Method | univatiate analysis | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | cardiac operation | |
| Group | Cp≤0.84 mL/mmHg(Treatment) | Cp 0.84-1.5 mL/mmHg & Cp≥1.5 mL/mmHg(Control) |
| Number | 58 | 60(Cp 0.84-1.5mL/mmHg), 57(Cp≥1.5mL/mmHg) |
| Age | 27±8 years | 29±9 years(Cp 0.84-1.5mL/mmHg), 30±11 years(Cp≥1.5mL/mmHg) |
| Gender (Male: Female) | 10:48 | 20:40(Cp 0.84-1.5 mL/mmHg; '16:41(Cp≥1.5mL/mmHg) |
| Marker Level | 26(44%) | 40(67%)(Cp 0.84-1.5mL/mmHg), 40(70%)(Cp≥1.5mL/mmHg) |
